Gp41 mutants and their use as hiv therapeutics

Details Gp41 mutants and their use as hiv therapeutics Gp41 mutants and their use as hiv therapeutics

A - Human Necessities

61

K

A61K 38/16 (2006.01) A61K 31/70 (2006.01) A61K 39/21 (2006.01) A61K 48/00 (2006.01) C07K 14/16 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2150028

Methods and therapeutic compositions for the treatment of HIV infection involving the administration of a mutant gp41 polypeptide, particularly a gp41 polypeptide of HIV.

Affiliated with

Also associated with

Rating

Gp41 mutants and their use as hiv therapeutics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gp41 mutants and their use as hiv therapeutics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gp41 mutants and their use as hiv therapeutics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1833246